North America Antibody Drug Conjugates Market

North America Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application (Breast Cancer, Blood Cancer, Urothelial Cancer & Bladder Cancer, and Others), By Technology, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-9016 Publication Date: May-2022 Number of Pages: 84
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
TABLE 1 North America Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 2 North America Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Antibody Drug Conjugates Market
TABLE 4 Acquisition & mergers – Antibody Drug Conjugates Market
TABLE 5 Approvals and trials– Antibody Drug Conjugates Market
TABLE 6 North America Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 7 North America Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 8 North America Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 9 North America Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 10 North America Blood Cancer Market by Country, 2018 - 2021, USD Million
TABLE 11 North America Blood Cancer Market by Country, 2022 - 2028, USD Million
TABLE 12 North America Urothelial Cancer & Bladder Cancer Market by Country, 2018 - 2021, USD Million
TABLE 13 North America Urothelial Cancer & Bladder Cancer Market by Country, 2022 - 2028, USD Million
TABLE 14 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 15 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 16 North America Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 17 North America Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 18 North America Cleavable Linker Market by Country, 2018 - 2021, USD Million
TABLE 19 North America Cleavable Linker Market by Country, 2022 - 2028, USD Million
TABLE 20 North America Non-Cleavable Linker Market by Country, 2018 - 2021, USD Million
TABLE 21 North America Non-Cleavable Linker Market by Country, 2022 - 2028, USD Million
TABLE 22 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 23 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 24 North America Antibody Drug Conjugates Market by Country, 2018 - 2021, USD Million
TABLE 25 North America Antibody Drug Conjugates Market by Country, 2022 - 2028, USD Million
TABLE 26 US Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 27 US Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 28 US Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 29 US Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 30 US Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 31 US Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 32 Canada Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 33 Canada Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 34 Canada Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 35 Canada Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 36 Canada Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 37 Canada Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 38 Mexico Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 39 Mexico Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 40 Mexico Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 41 Mexico Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 42 Mexico Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 43 Mexico Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 44 Rest of North America Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 45 Rest of North America Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 46 Rest of North America Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 47 Rest of North America Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 48 Rest of North America Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 49 Rest of North America Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 50 Key Information – Takeda Pharmaceutical Company Limited
TABLE 51 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 52 KEY INFORMATION – ASTRAZENECA PLC
TABLE 53 Key Information – GlaxoSmithKline PLC
TABLE 54 Key Information – Pfizer, Inc.
TABLE 55 key information – Astellas Pharma, Inc.
TABLE 56 Key Information – Gilead Sciences, Inc.
TABLE 57 Key Information – Seagen Inc.
TABLE 58 Key Information – ADC Therapeutics SA
TABLE 59 Key Information – Daiichi Sankyo Company, Limited

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2018, May – 2022, Mar) Leading Players
FIG 5 Recent strategies and developments: Takeda Pharmaceutical Company Limited
FIG 6 Recent strategies and developments: Gilead Sciences, Inc.
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo